IDENTIFICATION AND MOLECULAR BASIS FOR EFFICIENT ANTIFREEZE PROTEIN ENHANCERS

高效抗冻蛋白增强剂的鉴定和分子基础

基本信息

  • 批准号:
    9072711
  • 负责人:
  • 金额:
    $ 10.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-01-01 至 2020-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Antifreeze proteins (AFPs) are natural antifreeze molecules that have been found in many organisms including fish, insects, plants, bacteria, and fungi. AFPs exhibit great structural diversity, while they are all characterized by their unique ability to depress the freezing point of water without affecting the melting point apparently. The resulting difference between the melting point and the freezing point, referred to as thermal hysteresis (TH), is generally used as a measure of the antifreeze activities of AFPs. AFPs and co-solutes in body-fluids of cold-adapted organisms are responsible for survival in cold environments. Certain small molecule and macromolecule co-solutes can further enhance the antifreeze activity of AFPs, referred to as enhancers, and they usually do not have TH activity, but can bind to AFP through ionic interactions, hydrogen bonding, and/or hydrophobic interactions. AFP-based antifreeze systems (AFP plus enhancer) are much more effective and their uses are more environmentally friendly in comparison to conventional antifreezes, making them intriguing alternatives to conventional antifreezes in particular in biomedical fields. The proposed research will use series of beetle AFP-small molecule enhancer systems, in which small molecule enhancers display a wide range of antifreeze enhancement abilities. We will determine the binding characteristics between AFPs and enhancers using chemical and biophysical approaches in these systems and unravel the AFP-enhancer affinity in highly efficient AFP systems. We will also determine the factors that can affect the binding in the AFP-enhancers systems. The salt effects will be determined. We will optimize these factors in the proposed functional examinations of the AFP-enhancer systems. Quantitative understanding AFP-based antifreeze systems would help unravel survival strategy in cold-adapted organisms and lead to rational development of highly efficient cold preservation, antifreeze systems for practical biomedical applications, such as in preservation solutions for organ, tissue and cell transplantation, cryopreservation, and cryosurgery.
 描述(由应用提供):抗冻蛋白(AFP)是天然的抗冻分子,在许多生物体中都发现了,包括鱼类,昆虫,植物,细菌和真菌。 AFP揭露了巨大的结构多样性,而它们的特征都以其独特的能力来抑制水的冰点而不影响熔点。熔点和冰点之间的差异(称为热磁滞(Th))通常用作AFPS的防冻剂活性的量度。冷适应生物体的身体流体中的AFP和共晶负责在寒冷的环境中生存。某些小分子和大分子共糖可以进一步增强AFP的抗冻活性,称为增强子,通常没有TH活性,但可以通过离子相互作用,氢键,/或疏水性相互作用与AFP结合。基于AFP的防冻系统(AFP Plus增强剂)更有效,与常规防冻剂相比,它们的使用更加环保,这使它们是在生物医学领域中特别是传统的防冻剂的替代品。拟议的研究将使用一系列甲虫AFP-SMALL分子增强剂,其中小分子增强剂具有广泛的防冻剂增强能力。我们将使用这些系统中的化学和生物物理方法来确定AFP和增强子之间的结合特性,并在高效的AFP系统中揭示AFP-Enhancer亲和力。我们还将确定可能影响AFP-Enhancer系统中结合的因素。将确定盐效应。我们将在AFP-Enhancer系统的拟议功能检查中优化这些因素。定量理解基于AFP的防冻系统将有助于揭开冷适应生物体的生存策略,并导致高效的冷冻保存,用于实用生物医学应用的防冻剂系统的理性发展,例如用于器官,组织和细胞移植,冷冻保存和哭泣的器官,组织和细胞的制备解决方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Xin Wen的其他基金

Characterization of JT-4-173, a Potent Antiviral that Inhibits HIV-1 by a Novel Mechanism of Action
JT-4-173 的表征,一种通过新颖作用机制抑制 HIV-1 的强效抗病毒药物
  • 批准号:
    10762518
    10762518
  • 财政年份:
    2023
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
Identification and Molecular Basis for Efficient Antifreeze Protein Enhancers
高效抗冻蛋白增强剂的鉴定和分子基础
  • 批准号:
    8015326
    8015326
  • 财政年份:
    2009
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
Identification and Molecular Basis for Efficient Antifreeze Protein Enhancers
高效抗冻蛋白增强剂的鉴定和分子基础
  • 批准号:
    7933388
    7933388
  • 财政年份:
    2009
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
IDENTIFICATION AND MOLECULAR BASIS FOR EFFICIENT ANTIFREEZE PROTEIN ENHANCERS
高效抗冻蛋白增强剂的鉴定和分子基础
  • 批准号:
    10466921
    10466921
  • 财政年份:
    2009
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
IDENTIFICATION AND MOLECULAR BASIS FOR EFFICIENT ANTIFREEZE PROTIEN ENHANCERS
高效抗冻蛋白增强剂的鉴定和分子基础
  • 批准号:
    8823794
    8823794
  • 财政年份:
    2009
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
IDENTIFICATION AND MOLECULAR BASIS FOR EFFICIENT ANTIFREEZE PROTIEN ENHANCERS
高效抗冻蛋白增强剂的鉴定和分子基础
  • 批准号:
    8448640
    8448640
  • 财政年份:
    2009
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
Identification and Molecular Basis for Efficient Antifreeze Protein Enhancers
高效抗冻蛋白增强剂的鉴定和分子基础
  • 批准号:
    7558904
    7558904
  • 财政年份:
    2009
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
IDENTIFICATION AND MOLECULAR BASIS FOR EFFICIENT ANTIFREEZE PROTEIN ENHANCERS
高效抗冻蛋白增强剂的鉴定和分子基础
  • 批准号:
    10268213
    10268213
  • 财政年份:
    2009
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
Identification and Molecular Basis for Efficient Antifreeze Protein Enhancers
高效抗冻蛋白增强剂的鉴定和分子基础
  • 批准号:
    7749942
    7749942
  • 财政年份:
    2009
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
IDENTIFICATION AND MOLECULAR BASIS FOR EFFICIENT ANTIFREEZE PROTIEN ENHANCERS
高效抗冻蛋白增强剂的鉴定和分子基础
  • 批准号:
    8625766
    8625766
  • 财政年份:
    2009
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:

相似国自然基金

基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
  • 批准号:
    32360190
  • 批准年份:
    2023
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
  • 批准号:
    82304698
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
  • 批准号:
    62302456
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
  • 批准号:
    32301185
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
  • 批准号:
    32370941
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Alterations in Microglial function moderate the development of maladaptive drinking behaviors following early life stress and are exacerbated by ethanol consumption
小胶质细胞功能的改变会减缓早期生活压力后不良饮酒行为的发展,并因乙醇消耗而加剧
  • 批准号:
    10680078
    10680078
  • 财政年份:
    2023
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
CB1-mediated signaling in developmental ethanol effects
CB1 介导的信号传导对发育乙醇的影响
  • 批准号:
    10519734
    10519734
  • 财政年份:
    2023
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
  • 批准号:
    10591606
    10591606
  • 财政年份:
    2022
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
An innovative non-thiazolidinedione pan-PPAR agonist therapeutic for Alcoholic Hepatitis
一种创新的非噻唑烷二酮类泛 PPAR 激动剂,用于治疗酒精性肝炎
  • 批准号:
    10482468
    10482468
  • 财政年份:
    2022
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
  • 批准号:
    10409263
    10409263
  • 财政年份:
    2022
  • 资助金额:
    $ 10.95万
    $ 10.95万
  • 项目类别: